Clinical trials
Phase 4 Acute Coronary Syndrome trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
56 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 5 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 8 |
| 2015 | 3 |
| 2016 | 5 |
| 2017 | 4 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 5 |
| 2022 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 56 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The First Affiliated Hospital with Nanjing Medical University | 3 |
| Azienda Policlinico Umberto I | 2 |
| Kyoto University, Graduate School of Medicine | 2 |
| Associação Fundo de Incentivo à Pesquisa | 1 |
| Beijing Anzhen Hospital | 1 |
| Campus Bio-Medico University | 1 |
| Catholic University of the Sacred Heart | 1 |
| Centro Hospitalario La Concepcion | 1 |
| Chung-Ang University | 1 |
| Clearstream Technologies Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acute Coronary Syndrome | 56 |
| Coronary Artery Disease | 6 |
| ST Elevation Myocardial Infarction | 6 |
| Myocardial Infarction | 5 |
| Angina, Unstable | 4 |
| Coronary Disease | 3 |
| Non-ST Elevated Myocardial Infarction | 3 |
| Angina, Stable | 2 |
| Diabetes Mellitus | 2 |
| Diabetes Mellitus, Type 2 | 2 |
Trials
Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.